Psoriasis Stocks List

Psoriasis Stocks Recent News

Date Stock Title
May 10 CHRS Coherus BioSciences, Inc. (NASDAQ:CHRS) Q1 2024 Earnings Call Transcript
May 10 ABBV Ironwood (IRWD) Q1 Earnings & Revenues Fall Shy of Estimates
May 10 ABBV 3 Rock-Solid Dividend Stocks That Are Ideal for Retirees
May 10 CANF Can-Fite BioPharma and Nutriband Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
May 10 CANF Can-Fite receives FDA IND clearance for Phase IIb MASH treatment trial
May 10 CHRS Coherus BioSciences, Inc. (CHRS) Q1 2024 Earnings Call Transcript
May 9 CHRS Coherus BioSciences (CHRS) Reports Q1 Loss, Misses Revenue Estimates
May 9 CHRS Coherus BioSciences Non-GAAP EPS of -$0.32 misses by $0.11, revenue of $77.1M misses by $6.65M
May 9 CHRS Coherus BioSciences Reports First Quarter 2024 Financial Results and Provides Business Update
May 9 CANF Can-Fite stock up on FDA IND clearance for namodenoson to treat MASH patients in mid-stage study
May 9 BDRX Biodexa Looks To Prevent Or Delay The Worst Outcomes For Adolescents And Young Adults With Devastating Precancerous Condition
May 9 BHC Salix Pharmaceuticals announces Bellamy Young as Spokesperson for Xifaxan(R) (rifaximin)
May 9 CHRS Coherus Announces Full Repayment of Pharmakon Advisors $75 Million Term Loan
May 9 ABBV Q1 2024 Regenxbio Inc Earnings Call
May 9 CANF Can-Fite: FDA Grants IND Clearance for Namodenoson to Treat MASH Patients in a Phase IIb Study
May 8 CHRS Coherus BioSciences Q1 2024 Earnings Preview
May 8 BIIB Jeff Auxier's Firm Dissolves Textainer Group Position, Trims Biogen
May 8 BIIB Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
May 8 CHRS When Can We Expect A Profit From Coherus BioSciences, Inc. (NASDAQ:CHRS)?
May 8 CHRS Coherus Announces Clinical Collaboration with the Cancer Research Institute for a Novel Combination Evaluating LOQTORZI® (toripalimab-tpzi) with ENB Therapeutics' ENB-003 for the Treatment of Ovarian Cancer
Psoriasis

Psoriasis is a long-lasting autoimmune disease characterized by patches of abnormal skin. These skin patches are typically red, dry, itchy, and scaly. On people with darker skin the patches may be purple in colour. Psoriasis varies in severity from small, localized patches to complete body coverage. Injury to the skin can trigger psoriatic skin changes at that spot, which is known as the Koebner phenomenon.There are five main types of psoriasis: plaque, guttate, inverse, pustular, and erythrodermic. Plaque psoriasis, also known as psoriasis vulgaris, makes up about 90 percent of cases. It typically presents as red patches with white scales on top. Areas of the body most commonly affected are the back of the forearms, shins, navel area, and scalp. Guttate psoriasis has drop-shaped lesions. Pustular psoriasis presents as small non-infectious pus-filled blisters. Inverse psoriasis forms red patches in skin folds. Erythrodermic psoriasis occurs when the rash becomes very widespread, and can develop from any of the other types. Fingernails and toenails are affected in most people with psoriasis at some point in time. This may include pits in the nails or changes in nail color.Psoriasis is generally thought to be a genetic disease that is triggered by environmental factors. In twin studies, identical twins are three times more likely to be affected compared to non-identical twins. This suggests that genetic factors predispose to psoriasis. Symptoms often worsen during winter and with certain medications, such as beta blockers or NSAIDs. Infections and psychological stress can also play a role. Psoriasis is not contagious. The underlying mechanism involves the immune system reacting to skin cells. Diagnosis is typically based on the signs and symptoms.There is no cure for psoriasis; however, various treatments can help control the symptoms. These treatments include steroid creams, vitamin D3 cream, ultraviolet light and immune system suppressing medications, such as methotrexate. About 75 percent of cases can be managed with creams alone. The disease affects two to four percent of the population. Men and women are affected with equal frequency. The disease may begin at any age, but typically starts in adulthood. Psoriasis is associated with an increased risk of psoriatic arthritis, lymphomas, cardiovascular disease, Crohn's disease and depression. Psoriatic arthritis affects up to 30 percent of individuals with psoriasis.

Browse All Tags